ARS Pharmaceuticals names Donn Casale as CEO, replacing co-founder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. AAPL
5. NUE
6. AZN
7. TRMD
8. ONON
9. BETR
10. NVDA

Go back to ARS Pharmaceuticals names Donn Casale as CEO, replacing co-founder
(NASDAQ: SPRY) Delayed: 4.15 --0 (-0%)
Previous Close $4.15    52 Week High $ 
Open $4.10    52 Week Low $ 
Day High $4.20    P/E N/A 
Day Low $4.10    EPS $ 
Volume 316,702